Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Alexander Schirger"'
Autor:
Alexander Schirger
Publikováno v:
Acta Medica, Vol 42, Iss 1, Pp 29-31 (1999)
Article without abstract.
Externí odkaz:
https://doaj.org/article/73e8dfa09bf64b0cacffe4958efb33fa
Publikováno v:
Mayo Clinic Proceedings. 75:437-444
To determine how often patients with renal artery stenosis (RAS) managed without revascularization progress to accelerated hypertension and/or renal failure.We examined the outcomes of 68 patients (mean +/- SEM age, 71.8 +/- 0.9 years) with high-grad
Autor:
Alexander, Schirger
Publikováno v:
International angiology : a journal of the International Union of Angiology. 33(1)
Autor:
Andrew G. Moore, Sheldon G. Sheps, Christopher A. Carlson, Gary L. Schwartz, Prince K. Zachariah, Alexander Schirger
Publikováno v:
The Journal of Clinical Pharmacology. 30:1012-1019
The blood pressure response to a new sustained-release formulation of nifedipine was evaluated in an 8-week, double-blind, placebo-controlled study. Twenty-nine patients with mild essential hypertension were randomized to receive placebo (N = 9), 30
Publikováno v:
The American journal of medicine. 114(9)
Despite the advances in antihypertensive therapy and renal revascularization, there remains a group of patients in whom renovascular disease leads to renal atrophy and treatment-resistant hypertension.We performed an observational cohort study in whi
Publikováno v:
The New England journal of medicine. 348(2)
Autor:
Alexander Schirger, Anthony W. Stanson, Patrick F. Sheedy, Stephen C. Textor, C. Michael Johnson, Paul B. Kos, Michael A. McKusick, Frank S. Bonelli, Timothy J. Welch
Publikováno v:
Mayo Clinic proceedings. 70(11)
Objective To review the results of percutaneous transluminal renal artery angloplasty (PTRA), including technical success and clinical outcome, at Mayo Clinic Rochester. Design We retrospectively reviewed our experience with 320 patients who underwen
Publikováno v:
American Journal of Hypertension. 14:A254-A255
Publikováno v:
Cardiovascular drugs and therapy. 6(2)
HN-10200, a nonselective inhibitor of phosphodiesterase, has positive inotropic and vasodilator activity. The present study was designed to determine the role of endothelium in causing relaxation to HN-10200 in isolated canine femoral and basilar art